CIK 0001770121 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Sana Biotechnology, Inc.
Sign in to watch- Ticker
- SANA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831381173
- Phone
- (206) 701-7914
- Business address
- 188 EAST BLAINE STREET, SUITE 350, SEATTLE, WA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-08 | FMR LLC 10% owner | Sale | −164,912 | $6.71 | $1.1M | 4,542,511 |
| 2025-01-08 | FMR LLC 10% owner | Sale | −1,000 | $7.26 | $7K | 4,541,511 |
| 2025-01-06 | Bishop Hans Edgar Director | Grant or award | +14,285 | 5,804,774 | ||
| 2025-01-02 | Wyrick Susan D. See Remarks | Option exercise | +5,000 | 155,512 | ||
| 2025-01-02 | Wyrick Susan D. See Remarks | Shares withheld for taxes | −1,566 | $1.65 | $3K | 153,946 |
| 2025-01-02 | Wyrick Susan D. See Remarks | Option exercise · Restricted Stock Units | −5,000 | 7,500 | ||
| 2024-12-13 | Wyrick Susan D. See Remarks | Grant or award · Restricted Stock Units | +3,400 | 3,400 | ||
| 2024-12-13 | Wyrick Susan D. See Remarks | Grant or award · Stock Option (Right to Buy) | +5,100 | 5,100 | ||
| 2024-10-07 | Bishop Hans Edgar Director | Grant or award | +5,938 | 5,790,489 | ||
| 2024-09-25 | Mulligan Richard Director | Sale 10b5-1 | −150,000 | $3.89 | $583K | 2,698,121 |
| 2024-09-24 | Mulligan Richard Director | Sale 10b5-1 | −150,000 | $4.08 | $613K | 2,848,121 |
| 2024-07-05 | Bishop Hans Edgar Director | Grant or award | +4,911 | 5,784,551 | ||
| 2024-06-06 | Yang Patrick Y Director | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2024-06-06 | Mulligan Richard Director | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2024-06-06 | NELSEN ROBERT Director | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2024-06-06 | Wilderotter Mary Agnes Director | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2024-06-06 | Seitz Michelle Director | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2024-06-06 | REICIN ALISE Director | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2024-06-06 | Cole Douglas G. Director | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2024-06-06 | Bishop Hans Edgar Director | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 |
Page 5 of 9 · 172 trades